Nasacort (Triamcinolone Acetonide)

Triamcinolone acetonide, the active ingredient in Nasacort, is a corticosteroid presented as a nasal spray for intranasal use. It reduces nasal inflammation associated with allergic rhinitis in adults and children.\n\nGNH India supplies Nasacort as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nasacort is a corticosteroid nasal spray indicated for conditions affecting the nasal mucosa.\n\nAllergic rhinitis: reduces nasal congestion, itching, and sneezing caused by seasonal or perennial allergens.\nPerennial allergic rhinitis: provides sustained symptom relief for year‑round allergy sufferers.\nSeasonal allergic rhinitis: alleviates symptoms during specific pollen or mold seasons.

Nasacort may cause local and systemic adverse reactions.\n\nCommon Side Effects:\n- Nasal irritation or burning sensation\n- Epistaxis (nosebleeds)\n- Headache\n- Throat irritation or dryness\n- Altered taste or bitter after‑taste\n\nSerious or Rare Side Effects:\n- Nasal septal perforation\n- Severe allergic reaction (anaphylaxis)\n- Vision changes or ocular pressure increase\n- Adrenal suppression with prolonged high‑dose use\n- Secondary infection of the nasal mucosa

Before using Nasacort, consider the following safety measures.\n\nPregnancy: consult a healthcare professional before use.\nPediatric use: safety established for children aged 2 years and older.\nRecent nasal surgery or infection: avoid use until resolved.\nDo not exceed the recommended daily dose.\nStore at room temperature: keep in the original container, protect from moisture and heat.

Nasacort can interact with other medications; review the following categories.\n\nMajor Interactions (Avoid):\n- Systemic corticosteroids: may increase risk of systemic glucocorticoid effects.\n- Strong CYP3A4 inhibitors (e.g., ketoconazole): may raise local drug exposure.\n\nModerate Interactions (Monitor Closely):\n- Antihistamines: additive drying of nasal mucosa.\n- Azole antifungals: potential pharmacokinetic interaction.\n- Nasal decongestant sprays: may heighten local irritation.